Amylyx Pharmaceuticals (AMLX) Stock Chart & Stock Price History $2.88 0.00 (0.00%) (As of 09/19/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Amylyx Pharmaceuticals Stock Price Performance5 Day Performance+10.69%1 Month Performance+31.82%3 Month Performance+79.01%6 Month Performance-1.02%Year-To-Date Performance-80.30%1 Year Performance-84.64% Receive AMLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsImminent FDA Decision Could End Obesity in America...This drug could end obesity in America... ...and spark a 224,000% sales surge for one tiny micro-cap stock. Channelnomics says it "Could have a greater impact on the world than artificial intelligence."Get the name of this stock here >>> AMLX Stock Chart for Thursday, September, 19, 2024 AMLX Chart by TradingView Amylyx Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/18/2024$2.92$2.88-1.37%$2.97$2.831.48 million shs$195.86 million09/17/2024$2.65$2.92+10.19%$2.97$2.791.67 million shs$198.58 million09/16/2024$2.62$2.65+1.15%$2.68$2.59732,382 shs$180.22 million09/13/2024$2.49$2.62+5.22%$2.69$2.48843,099 shs$178.37 million09/12/2024$2.57$2.49-3.11%$2.64$2.47891,635 shs$169.34 million09/11/2024$2.66$2.57-3.38%$2.66$2.371.70 million shs$174.78 million Get the Latest News and Ratings for AMLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/10/2024$2.52$2.66+5.56%$2.70$2.541.64 million shs$181.09 million09/09/2024$2.37$2.52+6.33%$2.54$2.281.31 million shs$171.56 million09/06/2024$2.20$2.37+7.73%$2.48$2.301.55 million shs$161.17 million09/05/2024$2.09$2.20+5.26%$2.22$2.09492,596 shs$149.61 million09/04/2024$2.16$2.09-3.24%$2.17$2.08464,105 shs$142.13 million09/03/2024$2.22$2.16-2.70%$2.24$2.13582,330 shs$146.89 million09/02/2024$2.22$2.22$2.23$2.09414,100 shs$150.97 million08/30/2024$2.12$2.22+4.72%$2.23$2.09414,060 shs$150.97 million08/29/2024$2.09$2.12+1.44%$2.16$2.09380,641 shs$144.17 million08/28/2024$2.13$2.09-1.88%$2.16$2.05578,501 shs$142.13 million08/27/2024$2.21$2.13-3.62%$2.21$2.11510,937 shs$144.85 million08/26/2024$2.23$2.21-0.90%$2.30$2.19364,128 shs$150.29 million08/23/2024$2.22$2.23+0.45%$2.28$2.21340,379 shs$151.65 million08/22/2024$2.26$2.22-1.77%$2.28$2.17508,522 shs$150.97 million08/21/2024$2.26$2.26$2.32$2.22673,994 shs$153.69 million08/20/2024$2.20$2.26+2.73%$2.27$2.141.02 million shs$153.69 million08/19/2024$2.14$2.20+3.04%$2.24$2.121.19 million shs$149.61 million08/16/2024$2.16$2.14-1.16%$2.25$2.081.54 million shs$145.19 million08/15/2024$2.13$2.16+1.41%$2.19$2.111.60 million shs$146.89 million08/14/2024$1.99$2.13+7.04%$2.14$2.002.08 million shs$144.85 million08/13/2024$1.98$1.99+0.51%$2.02$1.921.16 million shs$135.33 million08/12/2024$1.90$1.98+4.21%$1.99$1.86780,890 shs$134.65 million08/09/2024$1.80$1.90+5.56%$1.93$1.77863,664 shs$129.21 million08/08/2024$1.88$1.80-4.26%$1.91$1.761.04 million shs$122.41 million08/07/2024$1.97$1.88-4.57%$1.99$1.871.42 million shs$127.85 million08/06/2024$1.97$1.97$2.02$1.91866,082 shs$133.97 million08/05/2024$2.02$1.97-2.48%$1.98$1.871.26 million shs$133.97 million08/02/2024$2.07$2.02-2.42%$2.06$1.961.55 million shs$137.38 million08/01/2024$2.06$2.07+0.49%$2.11$2.001.27 million shs$140.78 million07/31/2024$1.91$2.06+7.85%$2.09$1.911.61 million shs$140.09 million07/30/2024$1.94$1.91-1.55%$1.96$1.871.11 million shs$129.90 million07/29/2024$1.97$1.94-1.52%$2.00$1.89708,348 shs$131.94 million07/26/2024$1.92$1.97+2.60%$1.98$1.91808,997 shs$133.98 million07/25/2024$1.92$1.92$1.98$1.87413,229 shs$130.58 millionOur #1 Ticker for the Rare "Retirement Window" (Ad)We've only seen this happen three times in the past 20 years... And every time - like clockwork - it's minted an entire new class of millionaires.Click here for our #1 "Retirement Window" Stock >>>07/24/2024$1.96$1.92-2.04%$2.00$1.90623,523 shs$130.58 million07/23/2024$1.98$1.96-1.01%$2.00$1.91617,758 shs$133.30 million07/22/2024$2.02$1.98-1.98%$2.04$1.94906,913 shs$134.66 million07/19/2024$2.00$2.02+1.00%$2.04$1.93966,221 shs$137.38 million07/18/2024$2.12$2.00-5.66%$2.18$2.001.34 million shs$136.02 million07/17/2024$2.36$2.12-10.17%$2.37$2.091.84 million shs$144.18 million07/16/2024$2.16$2.36+9.26%$2.40$2.192.11 million shs$160.50 million07/15/2024$2.16$2.16$2.30$2.162.35 million shs$146.90 million07/12/2024$2.28$2.16-5.26%$2.42$2.133.16 million shs$146.89 million07/11/2024$2.07$2.28+10.14%$2.29$2.045.44 million shs$155.06 million07/10/2024$1.65$2.07+25.45%$2.11$1.699.60 million shs$140.78 million07/09/2024$1.65$1.65$1.68$1.621.31 million shs$112.22 million07/08/2024$1.72$1.65-4.07%$1.74$1.642.05 million shs$112.22 million07/05/2024$1.77$1.72-2.82%$1.77$1.71929,344 shs$116.98 million07/04/2024$1.77$1.77$1.79$1.69940,327 shs$120.38 million07/03/2024$1.74$1.77+1.72%$1.79$1.69940,327 shs$120.37 million07/02/2024$1.88$1.74-7.45%$1.89$1.741.75 million shs$118.34 million07/01/2024$1.90$1.88-1.05%$1.95$1.841.79 million shs$127.86 million06/28/2024$1.93$1.90-1.55%$2.10$1.889.98 million shs$129.22 million06/27/2024$1.83$1.93+5.46%$2.02$1.822.96 million shs$131.26 million06/26/2024$1.85$1.83-1.08%$1.90$1.811.83 million shs$124.46 million06/25/2024$1.83$1.85+1.09%$1.89$1.812.15 million shs$125.82 million06/24/2024$1.78$1.83+2.81%$1.91$1.792.83 million shs$124.45 million06/21/2024$1.65$1.78+7.88%$1.78$1.643.94 million shs$121.06 million06/20/2024$1.62$1.65+1.85%$1.68$1.621.22 million shs$112.22 million06/19/2024$1.62$1.62$1.67$1.621.06 million shs$110.17 million06/18/2024$1.65$1.62-1.82%$1.67$1.621.06 million shs$110.18 million Related Companies: Mesoblast Stock Chart ORIC Pharmaceuticals Stock Chart Rapport Therapeutics Stock Chart ProKidney Stock Chart Replimune Group Stock Chart Scholar Rock Stock Chart Humacyte Stock Chart Corbus Pharmaceuticals Stock Chart Annexon Stock Chart Exscientia Stock Chart Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AMLX) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredForget ChatGPT: Follow the AI Retirement PlaybookEveryone’s talking about AI right now, but I’ve been talking about it for years. Follow this two-part playb...Brownstone Research | SponsoredDump Nvidia, Apple, and Tesla Before It’s Too LateThe financial world is on high alert. Billionaires like Warren Buffett, Jeff Bezos, and Elon Musk are dumpi...InvestorPlace | SponsoredNew September Stock WarningSeptember is the most volatile month of the year for stocks. And after the brutal tech selloff, one Wall St...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amylyx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amylyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.